title: Obesity, insulin resistance and comorbidities? Mechanisms of association.
abstract: Overall excess of fat, usually defined by the body mass index, is associated with metabolic (e.g. glucose intolerance, type 2 diabetes mellitus (T2DM), dyslipidemia) and non-metabolic disorders (e.g. neoplasias, polycystic ovary syndrome, non-alcoholic fat liver disease, glomerulopathy, bone fragility etc.). However, more than its total amount, the distribution of adipose tissue throughout the body is a better predictor of the risk to the development of those disorders. Fat accumulation in the abdominal area and in non-adipose tissue (ectopic fat), for example, is associated with increased risk to develop metabolic and non-metabolic derangements. On the other hand, observations suggest that individuals who present peripheral adiposity, characterized by large hip and thigh circumferences, have better glucose tolerance, reduced incidence of T2DM and of metabolic syndrome. Insulin resistance (IR) is one of the main culprits in the association between obesity, particularly visceral, and metabolic as well as non-metabolic diseases. In this review we will highlight the current pathophysiological and molecular mechanisms possibly involved in the link between increased VAT, ectopic fat, IR and comorbidities. We will also provide some insights in the identification of these abnormalities.
authors.affiliation: Divisão de Endocrinologia e Metabolismo, Departamento de Clínica Médica, FMRP-USP, Ribeirão Preto, SP, Brazil.
authors.forename: Ana Valeria B
authors.initials: AV
authors.lastname: Castro
authors.affiliation: Diabetes and Obesity Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: Cathryn M
authors.initials: CM
authors.lastname: Kolka
authors.affiliation: Diabetes and Obesity Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: Stella P
authors.initials: SP
authors.lastname: Kim
authors.affiliation: Diabetes and Obesity Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: Richard N
authors.initials: RN
authors.lastname: Bergman
mesh_terms: D000273:Adipose Tissue / Q000473:pathology / Q000503:physiopathology*; D000818:Animals; D017209:Apoptosis; D050218:Body Fat Distribution; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications* / Q000378:metabolism; D007333:Insulin Resistance; D008928:Mitochondria / Q000378:metabolism; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D018570:Risk Assessment